Table 2.
Patient | Suppressed Serum TG Values (ng/mL) | |||||
---|---|---|---|---|---|---|
Before TTx | While Receiving TTx | Months After RAI Therapy | ||||
3 | 6 | 9 | 12 | |||
1 | 542 | 2201 | 1143 | 1802 | 1532 | 832 |
2 | 1471 | 1549 | 464 | 231 | 201 | 160 |
3 | 118 | 141 | 4.8 | — | <0.9 | <0.9 |
4a | 3101 | 5301 | 1311 | 864 | 548 | 478 |
5 | 1224 | 2041 | 382 | — | 194 | 141 |
6 | 1267 | 12,240 | 415 | 131 | 111 | 99.3 |
8 | 193 | 15.9 | 6.8 | 3.8 | — | — |
10 | 705 | 1054 | 1307 | — | — | — |
12 | <0.9 | <0.9 | — | <0.9 | — | — |
Abbreviation: —, no data.
TG Ab levels (IU/mL) were used for patient 4, who always had undetectable antigen levels. All other patients’ TG Ab levels were undetectable.